American Diabetes Association Alert(R) Day Video - Do You Have Diabetes?

* Reuters is not responsible for the content in this press release.

Tue Mar 24, 2009 12:17pm EDT

Online video is released to educate Americans about their risk of type 2
diabetes

PORT ST. LUCIE, Fla., March 24 /PRNewswire/ -- Today is American Diabetes
Alert(R) Day.  The American Diabetes Association urges all Americans to learn
about type 2 diabetes and whether they may have it.  To help educate the
public, the American Diabetes Association and one of its National Strategic
Partners, Liberty Medical Supply, Inc., have teamed up to provide an online
video that explains the symptoms and risks of diabetes.  
 
According to the American Diabetes Association, diabetes is a serious disease
that strikes nearly 24 million children and adults in the United States.  It
is named the "silent killer" because nearly one-fourth of those with the
disease - 5.7 million - do not know they have it.  Early diagnosis is critical
to successful treatment and delaying or preventing some of the complications
of diabetes, such as heart disease, blindness, kidney disease, stroke,
amputation, and death.

The "Do You Have Diabetes?" Internet video features Dr. Sue Kirkman, Vice
President of Clinical Affairs of the American Diabetes Association. It is
sponsored and produced by Liberty Medical Supply, Inc., a subsidiary of Medco
Health Solutions, Inc.  

"As the provider of diabetes supplies to more than one million Americans,
Liberty Medical is keenly aware of the need to educate the public about
diabetes, in the hope many Americans can prevent complications and get
treatment if necessary to avoid the terrible consequences of this disease,"
said Laizer Kornwasser, Medco Senior Vice President and Liberty Medical
President. "Liberty Medical has a long tradition of supporting the American
Diabetes Association's mission to further diabetes awareness and education. We
encourage others to share the new video on the Internet to spread the word
about diabetes and support the Alert Day campaign."

The video is available on Liberty Medical's website and
www.diabetes.org/alert. It can also be accessed directly at the following link
for viewing, linking and embedding on the Internet.
http://video.libertymedical.com/services/player/bcpid16574976001

About American Diabetes Association
The American Diabetes Association is leading the fight against the deadly
consequences of diabetes and fighting for those affected by diabetes. The
Association funds research to prevent, cure and manage diabetes; delivers
services to hundreds of communities; provides objective and credible
information; and gives voice to those denied their rights because of diabetes.
Founded in 1940, our mission is to prevent and cure diabetes and to improve
the lives of all people affected by diabetes. For more information please call
the American Diabetes Association at 1-800-DIABETES (1-800-342-2383) or visit
www.diabetes.org. Information from both these sources is available in English
and Spanish. Find out what is happening in your area.

To fulfill this mission, the American Diabetes Association funds research,
publishes scientific findings, provides information and other services to
people with diabetes, their families, health professionals and the public. The
Association is also actively involved in advocating for scientific research
and for the rights of people with diabetes.

About Liberty Medical 
Liberty is the nation's largest provider of blood glucose testing supplies and
related services to people with diabetes and today serves over one million
diabetes patients. Liberty also offers a full service pharmacy to meet
patients' medication needs and provides patient education to help its patients
better manage their health conditions. Through proactive patient outreach,
convenient home delivery and administrative support, Liberty makes it simple
for patients to obtain the supplies and medications they need, while
encouraging compliance with physicians' orders. More information about Liberty
can be found on the Company's website at www.libertymedical.com. 

About Medco
Medco Health Solutions, Inc. (NYSE: MHS) is the nation's leading pharmacy
benefit manager based on its 2007 total net revenues of more than $44 billion.
 Medco's prescription drug benefit programs, covering approximately
one-in-five Americans, are designed to drive down the cost of pharmacy health
care for private and public employers, health plans, labor unions and
government agencies of all sizes, for individuals served by the Medicare Part
D Prescription Drug Program, and those served by Medco's specialty pharmacy
segment, Accredo Health Group.  Medco, the world's most advanced pharmacy(R),
is positioned to serve the unique needs of patients with chronic and complex
conditions through its Medco Therapeutic Resource Centers(R), including its
enhanced diabetes pharmacy care practice through the Liberty acquisition. 
Medco is the highest-ranked independent pharmacy benefit manager on the 2008
Fortune 100 list. On the Net: http://www.medcohealth.com.

This press release contains "forward-looking statements" as that term is
defined in the Private Securities Litigation Reform Act of 1995. These
statements involve risks and uncertainties that may cause results to differ
materially from those set forth in the statements. No forward-looking
statement can be guaranteed, and actual results may differ materially from
those projected. We undertake no obligation to publicly update any
forward-looking statement, whether as a result of new information, future
events, or otherwise. Forward-looking statements in this press release should
be evaluated together with the risks and uncertainties that affect our
business, particularly those mentioned in the Risk Factors section of the
Company's Annual Report on Form 10-K and Quarterly Reports on Form 10-Q filed
with the Securities and Exchange Commission. 


SOURCE  Medco Health Solutions, Inc.

Ann Smith of Medco Health Solutions, Inc., +1-201-269-5984,
Ann_Smith@medco.com
Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.